Industry reports
Editor highlights

Publication dates

data types

Chemokine Market and Forecasts, April 2014

You might be interested in: clinical trial, cell therapy, hair loss, more »


 
1-10 of 38 reports for Chemokine

Biological Therapy Market in The United States

  • Industry report
  • April 2012
  • 9 pages

... Was developed in il-6h11546/h11546 mice. These results suggest that il-1h9252 and tnf-h9251 play more crucial roles than il-6 or chemokines in this model. Because arthritis was also developed in scid mice ...

Biological Therapy Sector in South Korea

  • Industry report
  • April 2012
  • 11 pages
  • by Corporation

... As the test extract for subsequent experiments because of more inhibitory capacity than the other solvents, and its effects on the release of chemokines, including tarc, rantes, and mdc, from hacat cells were ...

U.S. Biological Therapy Business

  • Industry report
  • January 2013
  • 49 pages

... chemokines kinase kinase integrins kinase inhibitor de rooij, blood 2012; ponader, blood 2012; herman, abstract #185 cll cll cll cll correlates of response to fostamatinib patients on study bcr ...

Cytokine Sector in Germany

  • Industry report
  • July 2012
  • 9 pages
  • by Corporation

... Stopped disease progression in an ae patient [13]. Th1- and th2-type immune responses in ae have exten- sively been studied, but pro-inflammatory and regulatory chemokines as well as th17-type cytokines ...

Biological Therapy Business Brief

  • Industry report
  • July 2012
  • 12 pages
  • by Corporation

... Paralleled the activity of equal concentrations of the corticosteroid triamcinolone used as an effective inhibitor of cytokine/chemokine release in phk and human skin (figure 3). Concentrations of 50 ...

Biological Therapy Industry in Canada, The United States and The United Kingdom

  • Industry report
  • January 2012
  • 7 pages

... Cathelici- dins, indolicidin and bac2a, to those of the better-character- ized ll-37 with respect to antiendotoxin properties, chemo- taxis, and chemokine production. We found that indolicidin and bac2a have ...

Biological Therapy Market in The United Kingdom

  • Industry report
  • April 2012
  • 10 pages

... Ccs induced production of cbpa- and ply-specific antibodies in association with several chemokines and cytokines, includ- ing gamma interferon (ifn-h9253) and interleukin-10 (il-10) in mnc. The antibody ...

The Swiss Blood Supply Sector

  • Industry report
  • March 2012
  • 9 pages

... To different blood products. Concentra- tions of interleukin-6, il-6 (a), interleukin-8 (il-8) (b) as well as chemokine ligand 1 cxcl1 (c) in supernatants of human microvascular endothelial cells (hmvec). Hmvec ...

Pharmaceutical Market in India and The United Kingdom

  • Industry report
  • March 2012
  • 2 pages

... Of anti-mhc (h-2kd) class i antibody clone34-1-2s, points to the protective role of recipient t and b lymphocytes in suppressing trali (perhaps by modulating recipient chemokine production).[3] Passive ...

Biotechnology : Innovation and Technology Trends

  • Industry report
  • January 2012
  • 63 pages

... Impaired growth dysmorphogenesis altered differentiation macrophage cells Cell motility Growth factor release ecm interactions chemokine pathway endothelial cells Cytoskeletal cycle ...

» Purchase Premium Reports (From $ 125 - $ 1 874)

4 reports for Chemokine
Chemokine Therapeutics Corp. (CTI) - Strategic SWOT Analysis Review

Chemokine Therapeutics Corp. (CTI) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2014
  • by Global Data

Summary This comprehensive SWOT profile of Chemokine Therapeutics Corp. provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clear and ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.